Τίτλος:
ERCP-related adverse events: European Society of Gastrointestinal Endoscopy (ESGE) Guideline
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Main Recommendations Prophylaxis 1 ESGE recommends routine rectal administration of 100 mg of diclofenac or indomethacin immediately before endoscopic retrograde cholangiopancreatography (ERCP) in all patients without contraindications to nonsteroidal anti-inflammatory drug administration. Strong recommendation, moderate quality evidence. 2 ESGE recommends prophylactic pancreatic stenting in selected patients at high risk for post-ERCP pancreatitis (inadvertent guidewire insertion/opacification of the pancreatic duct, double-guidewire cannulation). Strong recommendation, moderate quality evidence. 3 ESGE suggests against routine endoscopic biliary sphincterotomy before the insertion of a single plastic stent or an uncovered/partially covered self-expandable metal stent for relief of biliary obstruction. Weak recommendation, moderate quality evidence. 4 ESGE recommends against the routine use of antibiotic prophylaxis before ERCP. Strong recommendation, moderate quality evidence. 5 ESGE suggests antibiotic prophylaxis before ERCP in the case of anticipated incomplete biliary drainage, for severely immunocompromised patients, and when performing cholangioscopy. Weak recommendation, moderate quality evidence. 6 ESGE suggests tests of coagulation are not routinely required prior to ERCP for patients who are not on anticoagulants and not jaundiced. Weak recommendation, low quality evidence. Treatment 7 ESGE suggests against salvage pancreatic stenting in patients with post-ERCP pancreatitis. Weak recommendation, low quality evidence. 8 ESGE suggests temporary placement of a biliary fully covered self-expandable metal stent for post-sphincterotomy bleeding refractory to standard hemostatic modalities. Weak recommendation, low quality evidence. 9 ESGE suggests to evaluate patients with post-ERCP cholangitis by abdominal ultrasonography or computed tomography (CT) scan and, in the absence of improvement with conservative therapy, to consider repeat ERCP. A bile sample should be collected for microbiological examination during repeat ERCP. Weak recommendation, low quality evidence. © Georg Thieme Verlag KG Stuttgart New York.
Συγγραφείς:
Dumonceau, J.-M.
Kapral, C.
Aabakken, L.
Papanikolaou, I.S.
Tringali, A.
Vanbiervliet, G.
Beyna, T.
Dinis-Ribeiro, M.
Hritz, I.
Mariani, A.
Paspatis, G.
Radaelli, F.
Lakhtakia, S.
Veitch, A.M.
Van Hooft, J.E.
Περιοδικό:
Gastrointestinal Endoscopy
Εκδότης:
Georg Thieme Verlag
Λέξεις-κλειδιά:
anticoagulant agent; antithrombocytic agent; epinephrine; nitric acid derivative; nonsteroid antiinflammatory agent; octreotide; proteinase inhibitor; proton pump inhibitor; Ringer lactate solution; somatostatin, antibiotic prophylaxis; blood clotting test; cannulation; cholangitis; endoscopic retrograde cholangiopancreatography; human; hydration; iatrogenic disease; medical society; pancreatitis; perforation; postoperative hemorrhage; practice guideline; priority journal; prophylaxis; randomized controlled trial (topic); Review; risk factor; sphincterotomy; adverse device effect; adverse event; endoscopic sphincterotomy; gastrointestinal endoscopy; pancreatic duct; self expandable metallic stent, Cholangiopancreatography, Endoscopic Retrograde; Endoscopy, Gastrointestinal; Humans; Pancreatic Ducts; Self Expandable Metallic Stents; Sphincterotomy, Endoscopic
